Post-approval studies (Phase 4)Ended earlyNCT05552859
What this trial is testing
Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment
Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Sanofi 62